Crossmark

Prognostic and predictive value of systemic inflammatory markers in patients with metastatic gastric and GEJ adenocarcinoma with PD-L1 CPS score ≥ 5: Turkish Oncology Group (TOG) study

Crossref DOI link: https://doi.org/10.1038/s41598-025-09707-3

Published Online: 2025-07-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mildanoglu, Maral Martin

Kutlu, Yasin

Bas, Onur

Koylu, Bahadır

Dae, Shute Ailia

Sakin, Abdullah

Erdem, Dilek

Sendur, Mehmet Ali Nahit

Tasci, Elif Senocak

Dane, Faysal

Kaya, Ali Osman

Aykan, Musa Baris

Ergun, Yakup

Biter, Sedat

Dizdar, Omer

Disel, Umut

Selcukbiricik, Fatih

Kose, Fatih

Olmez, Omer Fatih

Demir, Gokhan

Yalcin, Suayib

Bilici, Ahmet
License Information

Text and Data Mining valid from 2025-07-13

Version of Record valid from 2025-07-13
More Information

Article History

Received: 4 April 2025

Accepted: 30 June 2025

First Online: 13 July 2025

Declarations

:

: The authors declare no competing interests.

: All procedures were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study protocol was reviewed and approved (reference number: E-10840098-202.3.02-1273, 13 February 2025) by the Ethics Committee at Medipol University (Istanbul, Turkey).

: Written informed consent was obtained from all patients or their designated legal representatives.

Document is current

Any future updates will be listed below